Company
Adaptimmune Limited
Adaptimmune Limited is an active UK company (number 06456741), incorporated 2007, with 1 current director, Christopher James Hill. Source: Companies House, updated 4th October 2026.
Official record Companies House · updated 4th October 2026 · Sources
Network
The large node is Adaptimmune Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 19
- William Charles Bertrand 2025-2025 View profile
- Gavin Wood 2020-2025 View profile
- Margaret Henry 2019-2025 View profile
- Adrian George Rawcliffe 2017-2025 View profile
- Dr Helen Katrina Tayton-Martin 2017-2025 View profile
- Dr C Elliott Sigal 2014-2017 View profile
- David Morrell Mott 2014-2017 View profile
- Dr Peter Armstrong Thompson 2014-2017 View profile
- Dr Ali Behbahani 2014-2017 View profile
- Helen Katrina Tayton-Martin 2011-2014 View profile
- Dr Jonathan Kenneth Charles Knowles 2011-2016 View profile
- Ian Michael Laing 2008-2016 View profile
- George Edward Silvanus Robinson 2008-2014 View profile
- James Julian Noble 2008-2019 View profile
- Nicholas John Cross 2008-2014 View profile
- Dr Bent Karsten Jakobsen 2008-2014 View profile
- Patrick Charles Morrish Baddeley 2007-2008 View profile
- Margaret Henry 2014-2025 View profile
- Aldwych Secretaries Limited 2007-2014 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 19/12/2007
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Adaptimmune Therapeutics PLC
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Adaptimmune Limited
is controlled by Adaptimmune Therapeutics PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Adaptimmune Therapeutics PLC.
2 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
1 directors on the board
- Christopher James Hill Director · appointed 2025
Left in the last 12 months
- William Charles Bertrand Director · appointed 2025 · resigned 2025
- Adrian George Rawcliffe Director · appointed 2017 · resigned 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- A single director - no second pair of eyes on any decision
Where to look Suggested search: a second director to remove single-point control.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 06456741
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 4th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data